Malaria drug may help treat specific form of dementia
February 3rd, 2011 - 2:11 pm ICT by ANIWashington, Feb 3 (ANI): A new study has revealed that various drugs already on the market to treat malaria, angina pectoris or heart rhythm disturbances could also be used in treating a specific form of frontotemporal dementia.
Frontotemporal dementia is caused by the breakdown of nerve cells in the frontal and temporal region of the brain (fronto-temporal lobe), which leads to, among other symptoms, a change in personality and behaviour.
Some forms of frontotemporal dementia are caused by a genetically determined reduction of a hormone-like growth factor progranulin.
Anja Capell and Prof. Christian Haass have now shown that these drugs could increase the production of progranulin.
As for almost every other gene, there are also two copies of the progranulin gene in the cell. In patients with progranulin dependent frontotemporal dementia, one of the two copies is defective, leading to a 50 percent reduction in progranulin levels.
To rescue the lack of progranulin, the Munich researchers tested various substances for their ability to stimulate the remaining progranulin production and identified a drug called bafilomycin (BafA1).
They then examined the molecular mechanism underlying the impact of BafA1 on progranulin more closely. Growth factors such as progranulin are produced in cellular membrane inclusions, known as vesicles.
BafA1 has an alkalising effect on these vesicles. After administration of BafA1 the interior of the vesicles is less acidic - and this increases the production of progranulin.
This observation encouraged the researchers to investigate further alkalising substances for their ability to raise progranulin levels.
Among the substances that passed the test were three drugs that are already on the market to treat various diseases: a medication for angina pectoris (bepridil), one for heart rhythm problems (amiodarone) and the widely used malaria drug chloroquine.
Chloroquine increased the progranulin level not only in experiments with mouse cells to normal, but also in cells from patients with the defective progranulin gene.
The team will now investigate whether chloroquine actually helps against progranulin-dependent frontotemporal dementia.
The study is published in the online edition of Journal of Neuroscience. (ANI)
- New insight into the cause of common dementia - Nov 18, 2010
- Gene that protects against dementia in high-risk individuals found - Dec 23, 2010
- Dementia drug could be 'within our grasp', say Oz scientists - Oct 29, 2010
- Brit scientists identify gene clue to early dementia speed - Feb 15, 2010
- New drug targets for malaria cure - Jan 12, 2010
- Gout drug shows promise against angina - Jun 08, 2010
- Now, simple blood test to predict dementia risk - Mar 06, 2009
- How broccoli fights cancer - Jan 27, 2011
- Blood test predicts chance of dementia - Mar 06, 2009
- New gene study paves way for more anti-malaria treatments - Oct 11, 2010
- EPO doping 'can cut cerebral malaria related deaths' - Apr 22, 2011
- New risk factor for second-most-common cause of early dementia onset found - Feb 16, 2010
- Rare brain disorder which causes dementia is genetic - Nov 05, 2009
- New strategies reducing malaria deaths in Odisha (April 25 is World Malaria Day) - Apr 25, 2012
- New discovery sheds light on mechanisms underlying Parkinson's - Feb 10, 2010
Tags: amiodarone, angina pectoris, anja, bepridil, capell, cellular membrane, chloroquine, dementia, frontotemporal dementia, growth factors, haass, heart rhythm disturbances, heart rhythm problems, inclusions, malaria drug, molecular mechanism, munich, nerve cells, temporal lobe, temporal region